Report Overview This report focuses on the global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The following manufacturers are covered in this report. • • • • • • •
Galectin Therapeutics Merck & Co. F. Hoffman-La Roche Ltd. Pfizer Inc. InterMune Inc. ProMetic Life-Sciences Inc. La Jolla Pharmaceutical Company